共 50 条
- [31] IMPACT OF VARIANT HISTOLOGY ON RESPONSE TO NEOADJUVANT CHEMOTHERAPY FOR UROTHELIAL BLADDER CANCER JOURNAL OF UROLOGY, 2018, 199 (04): : E617 - E617
- [32] Re: Induction Chemotherapy for Unresectable Urothelial Carcinoma of the Bladder JOURNAL OF UROLOGY, 2011, 186 (05): : 1808 - 1808
- [33] Micropapillary Variant of Urothelial Carcinoma in a Hemodialysis Patient CASE REPORTS IN ONCOLOGY, 2022, 15 (01): : 462 - 468
- [36] MICROPAPILLARY DIFFERENTIATION VERSUS CONVENTIONAL UROTHELIAL CARCINOMA: EFFECTS OF NEOADJUVANT CHEMOTHERAPY AND CYSTECTOMY ON SURVIVAL JOURNAL OF UROLOGY, 2014, 191 (04): : E495 - E496
- [37] Re: Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant Chemotherapy JOURNAL OF UROLOGY, 2017, 197 (05): : 1360 - 1361
- [38] Re: Neoadjuvant Systemic Therapy or Early Cystectomy? Single-Center Analysis of Outcomes After Therapy for Patients With Clinically Localized Micropapillary Urothelial Carcinoma of the Bladder Editorial Comment JOURNAL OF UROLOGY, 2012, 187 (03): : 880 - 881
- [39] ADVERSE ONCOLOGIC OUTCOMES OF SQUAMOUS CELL CARCINOMA OF BLADDER AS COMPARED TO UROTHELIAL CARCINOMA JOURNAL OF UROLOGY, 2015, 193 (04): : E805 - E805